Considering we're talking about a sexually transmitted disease, the much higher prevalence in Africa of having multiple simultaneous sexual partners is surely relevant.
I also wonder if 'number of births' is not largely a proxy instead for the shift in the immune system of a woman while pregnant; in effect they tend to become slightly immunocompromised, probably as a means of preventing an immune response from harming the baby.
[1] - https://www.who.int/news-room/fact-sheets/detail/cervical-ca...
medically, not really. the vaccine acts the same. epidemiology wise, it makes it more effective, assuming the correct coverage.
I would just suggest that stating that an entire continent of different races/culture/religions "having multiple simultaneous partners" smells just a little bit of "savages over there", which given that we are talking about _evidence_ based outcomes, jars somewhat.
That's not a response. The multiple simultaneous sexual partners are relevant to the fact that prevalence of the disease in Africa is very high. This is not a vaccine-related question, so the action of the vaccine can't speak to it.
> I would just suggest that stating that an entire continent of different races/culture/religions "having multiple simultaneous partners" smells just a little bit of "savages over there"
Funny, if you look at my comment, you should see that it refers to "the much higher prevalence" of this behavior in Africa.
Does Ghana have a higher or lower prevalence compared to benin, egypt or eritrea?
Drugs, though, probably have very limited potential.
https://www.sciencealert.com/these-animals-can-t-get-cancer-...
https://en.wikipedia.org/wiki/Gall https://en.wikipedia.org/wiki/Burl